# PK Study of Testosterone Nasal Gel (TBS-2) in Healthy Premenopausal Women

> **NCT01364623** · PHASE1 · COMPLETED · sponsor: **Acerus Pharmaceuticals Corporation** · enrollment: 24 (actual)

## Conditions studied

- Female Sexual Dysfunction

## Interventions

- **DRUG:** Low dose testosterone nasal gel, single dose
- **DRUG:** Medium dose testosterone nasal gel, single dose
- **DRUG:** High dose testosterone nasal gel, single dose
- **DRUG:** Medium dose testosterone nasal gel, multiple dose

## Key facts

- **NCT ID:** NCT01364623
- **Lead sponsor:** Acerus Pharmaceuticals Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2012-01
- **Final completion:** 2012-02
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2019-10-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01364623

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01364623, "PK Study of Testosterone Nasal Gel (TBS-2) in Healthy Premenopausal Women". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01364623. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*